Literature DB >> 26573703

Impact of Adiposity on Incident Hypertension Is Modified by Insulin Resistance in Adults: Longitudinal Observation From the Bogalusa Heart Study.

Tao Zhang1, Huijie Zhang1, Shengxu Li1, Ying Li1, Yaozhong Liu1, Camilo Fernandez1, Emily Harville1, Lydia Bazzano1, Jiang He1, Wei Chen2.   

Abstract

Adiposity and insulin resistance are closely associated with hypertension. This study aims to investigate whether the association between adiposity and hypertension is modified by insulin resistance. The cohort consisted of 1624 middle-aged normotensive black and white adults aged 18 to 43 years at baseline who followed for 16 years on average. Overweight/obesity at baseline was defined as body mass index (BMI) ≥25, and insulin resistance was measured using homeostasis model assessment of insulin resistance. Prevalence of incident hypertension was compared between the insulin-sensitive adiposity and insulin-resistant adiposity groups. The prevalence of incident hypertension was higher in the insulin-resistant adiposity than in the insulin-sensitive adiposity group (32.1% versus 22.1%, P<0.001). In multivariable logistic analyses, adjusted for baseline age, race, sex, follow-up years, and smoking, baseline insulin-resistant obesity was associated with incident hypertension (odds ratio, 1.9; P=0.008). Odds ratios did not differ between blacks and whites (P=0.238). Of note, the odds ratios of BMI associated with hypertension significantly increased with increasing quartiles of baseline homeostasis model assessment (odds ratio, 1.3, 1.1, 1.5, and 2.5 in quartiles I, II, III, and IV, respectively; P=0.006 for trend). Slopes of increasing follow-up blood pressure with baseline BMI, measured as regression coefficients (β), were significantly greater in insulin-resistant than in insulin-sensitive individuals (β=0.74 versus β=0.35 for systolic blood pressure, P=0.004 for difference; β=0.51 versus β=0.23 for diastolic blood pressure, P=0.001 for difference). These findings suggest that insulin resistance has a synergistic effect on the obesity-hypertension association in young adults, indicating that the role of adiposity in the development of hypertension is modified by insulin resistance.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  adiposity; blood pressure; body mass index; longitudinal studies; obesity

Mesh:

Substances:

Year:  2015        PMID: 26573703      PMCID: PMC4679582          DOI: 10.1161/HYPERTENSIONAHA.115.06509

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  44 in total

1.  Temporal association between obesity and hyperinsulinemia in children, adolescents, and young adults: the Bogalusa Heart Study.

Authors:  S R Srinivasan; L Myers; G S Berenson
Journal:  Metabolism       Date:  1999-07       Impact factor: 8.694

2.  Insulin resistance and hypertension: new insights.

Authors:  Manoocher Soleimani
Journal:  Kidney Int       Date:  2015-03       Impact factor: 10.612

Review 3.  Obesity-associated hypertension: new insights into mechanisms.

Authors:  Kamal Rahmouni; Marcelo L G Correia; William G Haynes; Allyn L Mark
Journal:  Hypertension       Date:  2004-12-06       Impact factor: 10.190

Review 4.  Obesity and hypertension.

Authors:  N Mikhail; M S Golub; M L Tuck
Journal:  Prog Cardiovasc Dis       Date:  1999 Jul-Aug       Impact factor: 8.194

5.  Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity.

Authors:  T Ikeda; T Gomi; N Hirawa; J Sakurai; N Yoshikawa
Journal:  Hypertension       Date:  1996-05       Impact factor: 10.190

6.  Insulin resistance versus insulin secretion in the hypertension of obesity.

Authors:  N W Istfan; C S Plaisted; B R Bistrian; G L Blackburn
Journal:  Hypertension       Date:  1992-04       Impact factor: 10.190

7.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

Authors:  Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers
Journal:  Arch Intern Med       Date:  2008-08-11

8.  Hypertension and insulin resistance are not directly related in obese dogs.

Authors:  Albert P Rocchini; John Q Yang; Amy Gokee
Journal:  Hypertension       Date:  2004-03-08       Impact factor: 10.190

9.  Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010.

Authors:  Fangjian Guo; Di He; Wei Zhang; R Grace Walton
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

10.  Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

Authors:  Johan Arnlöv; Erik Ingelsson; Johan Sundström; Lars Lind
Journal:  Circulation       Date:  2009-12-28       Impact factor: 29.690

View more
  9 in total

1.  Temporal Relationship Between Childhood Body Mass Index and Insulin and Its Impact on Adult Hypertension: The Bogalusa Heart Study.

Authors:  Tao Zhang; Huijie Zhang; Ying Li; Dianjianyi Sun; Shengxu Li; Camilo Fernandez; Lu Qi; Emily Harville; Lydia Bazzano; Jiang He; Fuzhong Xue; Wei Chen
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

Review 2.  Risk of hypertension following perinatal adversity: IUGR and prematurity.

Authors:  Trassanee Chatmethakul; Robert D Roghair
Journal:  J Endocrinol       Date:  2019-07-01       Impact factor: 4.286

3.  Prevalence and Severity of High Blood Pressure Among Children Based on the 2017 American Academy of Pediatrics Guidelines.

Authors:  Atul K Sharma; Daniel L Metzger; Celia J Rodd
Journal:  JAMA Pediatr       Date:  2018-06-01       Impact factor: 16.193

4.  Prediction of incident hypertension and arterial stiffness using the non-insulin-based metabolic score for insulin resistance (METS-IR) index.

Authors:  Omar Yaxmehen Bello-Chavolla; Neftali E Antonio-Villa; Arsenio Vargas-Vázquez; Alexandro J Martagón; Roopa Mehta; Olimpia Arellano-Campos; Donaji V Gómez-Velasco; Paloma Almeda-Valdés; Ivette Cruz-Bautista; Marco A Melgarejo-Hernandez; Liliana Muñoz-Hernandez; Luz E Guillén; José de Jesús Garduño-García; Ulices Alvirde; Yukiko Ono-Yoshikawa; Ricardo Choza-Romero; Leobardo Sauque-Reyna; Ma Eugenia Garay-Sevilla; Juan M Malacara-Hernandez; María T Tusié-Luna; Luis M Gutierrez-Robledo; Francisco J Gómez-Pérez; Rosalba Rojas; Carlos A Aguilar-Salinas
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-07-18       Impact factor: 3.738

5.  Gender-specific predictive ability for the risk of hypertension incidence related to baseline level or trajectories of adiposity indices: a cohort study of functional community.

Authors:  Ya-Ke Lu; Jing Dong; Yue Sun; Li-Kun Hu; Yu-Hong Liu; Xi Chu; Yu-Xiang Yan
Journal:  Int J Obes (Lond)       Date:  2022-02-03       Impact factor: 5.095

6.  Long-term Impact of Temporal Sequence from Childhood Obesity to Hyperinsulinemia on Adult Metabolic Syndrome and Diabetes: The Bogalusa Heart Study.

Authors:  Tao Zhang; Huijie Zhang; Ying Li; Shengxu Li; Camilo Fernandez; Lydia Bazzano; Jiang He; Fuzhong Xue; Wei Chen
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

7.  Isolated systolic hypertension and insulin resistance assessment tools in young and middle-aged Chinese men with normal fasting glucose: a cross-sectional study.

Authors:  Qing Gu; Jian Meng; Xue Hu; Jun Ge; Sui Jun Wang; Xing Zhen Liu
Journal:  Sci Rep       Date:  2022-01-14       Impact factor: 4.379

8.  Evolution of target organ damage and haemodynamic parameters over 4 years in patients with increased insulin resistance: the LOD-DIABETES prospective observational study.

Authors:  Manuel Ángel Gómez-Marcos; José Ignacio Recio-Rodríguez; María Carmen Patino-Alonso; Cristina Agudo-Conde; Emiliano Rodríguez-Sanchez; Jose Angel Maderuelo-Fernandez; Leticia Gómez-Sánchez; Marta Gomez-Sanchez; Luís García-Ortiz
Journal:  BMJ Open       Date:  2016-06-01       Impact factor: 2.692

9.  The efficacy of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on insulin resistance in hypertensive patients: A protocol for a systematic review and meta-analysis.

Authors:  Jia Yao; Xiayu Gong; Xiaoyan Shi; Simin Fan; Junmin Chen; Qiu Chen
Journal:  Medicine (Baltimore)       Date:  2020-06-12       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.